Skip to content

The 95% Effective Dose of Remimazolam Tosilate for Induction of General Anesthesia in Elderly Patients

The 95% Effective Dose of Remimazolam Tosilate for Induction of General Anesthesia in Ederly Patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048137
Enrollment
Unknown
Registered
2021-07-04
Start date
2021-07-05
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general anesthesia

Interventions

Experimental group:Remimazolam Tosilate injection

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. ASA i-ii level; 2. Age > 65 years old; 3.BMI18~28; 4. Gender is not limited; 5. Patients who plan to undergo general anesthesia on an elective basis.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery; 2. Abnormal renal function (urea nitrogen >=1.5xULN, serum creatinine greater than the upper limit of normal); 3. Hypovolemia, shock or coma; 4. Uncontrolled hypertension (systolic blood pressure>160mmHg, diastolic blood pressure>90mmHg), suffering from mental system disease and long-term history of taking psychotropic drugs; coronary heart disease; 5. Cerebrovascular disease; 6. Severe arrhythmia; 7. Cognitive dysfunction; 8. Those who are allergic to or have contraindications to the components of benzodiazepines; 9. Pregnant or lactating female patients; 10. Have a history of drug dependence; 11. Have used other sedative drugs in the past week; 12. Participated in drug clinical trials as subjects within the past 3 months.

Design outcomes

Primary

MeasureTime frame
success rate of sedation;

Secondary

MeasureTime frame
blood pressure;heart rate;mood;use of drug during induction;depth of sedation;adverse reaction;time;Intraoperative awareness;degree of satisfaction;dream;

Countries

China

Contacts

Public ContactXia Zhongyuan

Renmin Hospital of Wuhan University

xiazhongyuan2005@aliyun.com+86 13808628560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026